Wheezing clinical trials at UCSF

1 in progress, 0 open to eligible people

Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness
Sorry, in progress, not accepting new patients
The primary objective of this study is to evaluate if Broncho-Vaxom® given to high risk infants for 10 days, monthly, for two consecutive years can increase time to occurrence of the first episode of wheezing lower respiratory tract illness (WLRI) during a three year observation period off therapy.
Oakland, California and other locations

Last updated: May 2022

Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness